A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol

BACKGROUND: Tubal ectopic pregnancy (tEP) is the most common life-threatening condition in gynaecology. Treatment options include surgery and medical management. Stable women with tEPs with pre-treatment serum human chorionic gonadotrophin (hCG) levels < 1000 IU/L respond well to outpatient medic...

Descripción completa

Detalles Bibliográficos
Autores principales: May, James, Duncan, Colin, Mol, Ben, Bhattacharya, Siladitya, Daniels, Jane, Middleton, Lee, Hewitt, Catherine, Coomarasamy, Arri, Jurkovic, Davor, Bourne, Tom, Bottomley, Cecilia, Peace-Gadsby, Alexandra, Doust, Ann, Tong, Stephen, Horne, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247635/
https://www.ncbi.nlm.nih.gov/pubmed/30458863
http://dx.doi.org/10.1186/s13063-018-3008-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247635/
https://www.ncbi.nlm.nih.gov/pubmed/30458863
http://dx.doi.org/10.1186/s13063-018-3008-6

Ejemplares similares